Objective Antiphospholipid antibodies (aPL) activate several cell types, such as endothelial
cells, monocytes, neutrophils, fibroblasts, trophoblasts and platelets, thus leading to …

Autoantibodies are implicated in various human diseases. In this review, the effects of three
different types of autoantibodies (antiphospholipid antibody, antithyroid antibody, and …

Background Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is
caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2 glycoprotein-I …

BACKGROUND: The Sapporo criteria for the diagnosis of the antiphospholipid syndrome
(APS) are based on the presence of antiphospholipid antibodies (APLA) and clinical criteria …

Objective To assess outcomes after 20 weeks of pregnancy according to autoantibody
profile and clinical presentation of maternal antiphospholipid syndrome (APS). Methods The …

Antiphospholipid syndrome (APS) is an autoimmune disorder in which autoantibody
production can lead to a hypercoagulable state, pregnancy failure and/or a multitude of …

The aim of this study was to understand the clinical features of antiphospholipid syndrome
(APS)-complicated pregnancies and evaluate risk factors for the adverse pregnancy …

Pregnancy morbidity is part of the clinical spectrum of the antiphospholipid syndrome (APS),
a chronic autoimmune condition serologically characterized by the persistent positivity of …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the
production of antiphospholipid antibodies (aPL) resulting in clinical complications such as …

Aim To analyse the clinical features, laboratory data, foetal–maternal outcomes, and follow-
up in a cohort of 247 women with obstetric antiphospholipid syndrome (OAPS). Methods The …